You need a PAID SUBSCRIPTION TO
HDCN before you
can access this material. A GREY CE Post-Test Link means that the
continuing education
credit feature is not yet ready for
use. | |
 |
Overview of Transplantation
Stephen Tomlanovich, M.D. |
 |
|
Extraskeletal Calcification in Uremia: Cardiovascular Implications
Isidro Salusky, M.D. |
| Lactic Acidosis
Harold Szerlip,
M.D., M.S. |
|
| Fluid Management and Hemodynamic Monitoring
Stephen Ruoss, M.D. |
| The Role of "V" in Peritoneal Dialysis
Outcomes and Adequacy
Bengt Lindholm, MD, PhD |
|
| Comparison between Daily and Slow Nocturnal Hemodialysis
Andreas Pierratos, M.D. |
| Daily and Nocturnal Hemodialysis: Is Renal Osteodystrophy Better?
Andreas Pierratos, M.D.
|
|
| The Impact of Short Daily Hemodialysis on Nutrition and Quality of Life
Jules Traeger, M.D., Ph.D. |
| Advances in Management of Acute Liver Failure
Roger Williams, MD, CBE, FRCP |
|
| End-of-Life Care in Nephrology: Symptom Management
Michael Germain, M.D. |
|
Pediatric Critical Care Nephrology
Timothy Bunchman, M.D. |
|
 |
Aldosterone, Salt, and Cardiac Fibrosis
John Funder, M.D., Ph.D. |
|
|
Glomerulonephritis: Anti-GBM Disease
Charles D. Pusey, M.D. |
|
| Kt/V, Body Mass
Determinants, and Survival
John T. Daugirdas, M.D. |
|
|
Solute
Control and Dose of Dialysis
William Clark, M.D. |
|
| Management
of the Nephrotic
Syndrome
Gerald B. Appel, M.D. |
|
| IgA
Nephropathy: Update
2001
Richard J. Glassock, M.D. |
|
| Treatment of
Membranous
Nephropathy
Daniel Cattran, M.D. |
|
| PD Adequacy Guidelines: What
Targets and Why?
John M. Burkart, M.D. |
|
| Drug Dosing in CRRT
Farivar Jahansouz, Pharm.D. |
| Physiology
of Peritoneal Dialysis
Peter G. Blake, M.D.
|
|
| Peritoneal Catheter
Placement
Martin J. Schreiber, Jr., M.D.
|
(More to come!)
| See each individual talk link for educational
objectives. |
 |
Gerald B. Appel, M.D.
Professor of
Clinical Medicine at Columbia University College of Physicians and
Surgeons; Director
of Clinical Nephrology at Columbia-Presbyterian Medical Center; New
York, NY.
Peter G. Blake, M.D. Associate Professor of
Medicine, University
of Western Ontario; Director, Peritoneal Dialysis, and Co-Director,
Optimal Dialysis
Research Unit, London Health Sciences Center, University of Western
Ontario, London, Ontario, Canada.
Timothy E. Bunchman, M.D.
Professor Pediatric Nephrology and
Transplantation at the University of Alabama in Birmingham, AL
John M. Burkart, M.D. Professor
of Internal
Medicine/Nephrology, at Wake Forest University School of Medicine,
Corporate Director
of Dialysis Program. Winston-Salem, N.C.
Daniel
Cattran, M.D.
Professor of Medicine, University of Toronto, Associate Director,
Division of
Nephrology, Toronto Hospital, Toronto, Ontario, Canada.
William Clark, M.D. Director of Hemodialysis Research, Baxter Healthcare, Inc.
Clinical Assistant Professor of Medicine, University of Indiana School of Medicine, Indianapolis, IN.
John Daugirdas, M.D. Professor of Medicine, University of
Illinois at Chicago
School of Medicine, Chicago, IL.
John Funder, M.D., Ph.D.
Professor of Medicine, University of Melbourne; Past Director, Baker Medical Research Institute;
Melbourne, Victoria, Australia.
Michael Germain, M.D.
Associate Professor of Medicine, Tufts University School of Medicine,
Boston, MA.
Richard J.
Glassock, M.D. Professor of Medicine (retired), University of
Kentucky, Lexington,
KY.
Farivar Jahansouz, Pharm.D. Transplant Pharmacist,
Cardiovascular
Center, University of California at San Diego, CA.
Bengt Lindholm, M.D., Ph.D. Associate Professor of
Medicine, Karolinska Institute, Stockholm, Sweden.
Andreas Pierratos, M.D. Associate Professor of Medicine,
Univeristy of Toronto School of Medicine, Humber River Regional
Medical Center, Toronto, Ontario, Canada.
Charles Pusey, M.D. Professor of Medicine, Imperial
College School of Medicine, Hammersmith Hospital, London, UK.
Stephen Ruoss, M.D. Associate Professor of Medicine, Stanford University School of Medicine,
Stanford, CA.
Harold Szerlip, M.D., M.S. Professor of Medicine, Medical College of Georgia, Augusta, GA.
Jules Traeger, M.D., Ph.D. Professor of Medicine, University of Lyon, France.
Isidro B. Salusky, M.D.
Professor of Pediatrics, University of California at Los
Angeles, CA
Martin J. Schreiber,
M.D. Attending Nephrologist and Medical Director, Continuous
Ambulatory Peritoneal
Dialysis Unit, and Medical Director, Home Dialysis Program,
Cleveland Clinic, Cleveland, OH.
Stephen Tomlanovich, M.D.
Professor of Medicine, University of California at San Francisco, San Francisco, CA.
Roger Williams, C.B.E., M.D., F.R.C.P.
Professor of Hepatology, University College London; Director, Institute of Hepatology, London, UK.
|
|  |
| Each talk, depending on its length,
is accredited
for up to 1.0 CME credit hours by the American Society of
Nephrology. Shorter
talks are organized into groups of two and paired with a CME
post-test, which
must be completed along with an evaluation form for 1.0 hour or
more of CME credit.
Selected talks are also configured to yield CEU Nursing Education
credits, provided
by the Renal Education Association. |
| | Date of Original Release: See
individual talks
CME / CEU Credit Eligible Through: See individual talks
CME / CEU
Credit Hours/Completion Time: See individual talks
Target Audiences:
For CME accredited talks: Nephrology Board and Recertification
candidates practicing
nephrologists and internists
For CEU accredited talks:
Nephrology Nurses and
Technicians.
Method of participation: Listen to the
talk, read the
PubMed abstracts linked to data slides and talk references, take
the post-test,
read the abstracts linked to post-test answer feedback material.
|
Chronic kidney disease affects 30-40 million Americans, of
whom several
thousand require renal replacement therapy. These selected lectures
are chosen
by the HDCN editor and ASN Postgraduate Medical Director to reflect
those areas
of practice of greatest interest to the clinician, and areas where
recent progress
has occurred. The web extension of these ASN/ISN lectures will
allow nephrologists
and other physicians who were unable to attend the live sessions to
gain similar
benefit from these presentations. Similarly, those talks chosen for
Nursing CEUs
will allow nephrology nurses, pharmacists, and technicians to also
get the educational
benefit of this material.
| ACCREDITATION
STATEMENTS: |
(1) The American Society of Nephrology is accredited by
the Accreditation
Council for Continuing Medical Education to provide continuing
medical education
for physicians.
(2) The Renal Education Association is
accredited by
the State of California Board of Nursing to provide continuing
education for nurses
(Provider number: CEP 13092).
(1) The American Society of Nephrology designates this
educational activity
for category 1 credit toward the AMA Physician's Recognition Award.
Each physician
should claim only those hours of credit that he/she actually spent
in the activity.
(2) The Renal Education Association designates this educational
activity for continuing
education credits (CEUs) for nurses. Each nurse should claim only
those hours
of credit that he/she actually spent in the activity.
| FACULTY DISCLOSURE
STATEMENTS : |
American Society of Nephrology, the Renal Education
Association, as well
as HDCN have conflict of interest policies that requires course
faculty to disclose
any real or apparent commercial financial affiliations related to
the content
of their presentations/materials. It is not assumed that these
financial interests
or affiliations will have an adverse impact on faculty
presentations; they are
simply noted here to fully inform participants.
Dr. Appel: No financial relationships with commercial
entities related to his presentation
Dr. Blake: Grants/Research
Support: Baxter Healthcare.
Dr. Burkart: Grants/Research
Support/Consultancy:
Baxter Healthcare.
Dr. Bunchman: Consultant: Dialysis Solutions, Inc.
Dr. Cattran: No financial relationships with commercial
entities related to his presentation
Dr. Clark: Employee: Baxter Healthcare, Inc.
Dr. Daugirdas: No financial relationships with commercial
entities related to his presentation
Dr. Funder: Grants or Research support: Pharmacia; Consultantships:
Pharmacia, Karobio, Ligand; stocks: Fauldings
Dr. Germain: No financial relationships with commercial
entities related to his presentation
Dr. Glassock: No financial relationships
with commercial entities related to his presentation
Dr. Jahansouz: No financial relationships with commercial
entities related to his presentation
Dr. Lindholm: Employee of Baxter Novum; Research and Grant Support
from Baxter Novum.
Dr. Pierratos: Stocks in Aksys
Dr. Pusey: No financial relationships
with commercial entities related to his presentation
Dr. Ruoss: No financial relationships
with commercial entities related to his presentation
Dr. Salusky: Research is supported by NIH. Consultancy: Genzyme, and Abbott. Stock ownership: Genzyme.
Dr. Tomlanovich: No financial relationships
with commercial entities related to his presentation
Dr. Szerlip: No financial relationships
with commercial entities related to his presentation
Dr. Schreiber: Grants/Research
Support and Consultant: Baxter
Dr. Traeger: NO financial relationships with financial entities
related to his presentation
Dr. Williams: Advisory Board: Teraklin (MARS machine)
| DISCLOSURE OF
UNLABELED USE: |
This educational activity may contain discussion of
published and/or
investigational uses of agents that are not indicated by FDA. The
American Society
of Nephrology, the Renal Education Association, and HDCN do not
recommend the
use of any agent outside of the labeled indications. Please refer
to the official
prescribing information for each product for discussion of approved
indications,
contraindications and warnings.
Participants have an implied responsibility to use the
newly acquired
information to enhance patient outcomes and their own professional
development.
The information presented in this activity is not meant to serve as
a guideline
for patient management. Any procedures, medications, or other
courses of diagnosis
or treatment discussed or suggested in this activity should not be
used by clinicians
without evaluation of their patient's conditions and possible
contraindications
on dangers in use, review of any applicable manufacturer's product
information,
and comparison with recommendations of other authorities.
To complete this educational activity, the user will need Windows or Macintosh operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or
the Real Player from Real Media (www.real.com) is required and either can be downloaded for free
per instructions on the individual lecture pages. Acrobat Reader is required to print the CME or
CE certificate, and this can be download free from www.adobe.com.
For any questions concerning this activity please send an email to 
or call HDCN at 630-325-3276.
| |
